Posterior reversible encephalopathy syndrome following infliximab infusion

Journal of Pediatric Gastroenterology and Nutrition

Volumn 48, Issue 1, 2009, Pages 102-105

  Zamvar, Veena ^a,b   Sugarman, Ian D ^b   Tawfik, Rihab F ^c   MacMullen Price, Jeremy ^b   Puntis, John W L ^a  

^a Department of Paediatric Gastroenterology ^*  (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

^c PINDERFIELDS GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CEFOTAXIME; ERYTHROMYCIN; GADOLINIUM; HYDROCORTISONE; INFLIXIMAB; MESALAZINE; METRONIDAZOLE; PHENYTOIN; PREDNISOLONE; ANTIINFLAMMATORY AGENT; MONOCLONAL ANTIBODY;

ADOLESCENT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DISEASE CONTROL; HUMAN; HUMAN TISSUE; INFUSION; LABORATORY TEST; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARENTERAL NUTRITION; PHYSICAL EXAMINATION; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; TONIC CLONIC SEIZURE; ABDOMINAL PAIN; ANUS FISSURE; BRAIN DISEASE; CHEMICALLY INDUCED DISORDER; COLON RESECTION; DIARRHEA; ILEOSTOMY; SEIZURE; SYNDROME; VISUAL DISORDER;

ABDOMINAL PAIN; ADOLESCENT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; AZATHIOPRINE; BRAIN DISEASES; COLECTOMY; COLONOSCOPY; CROHN DISEASE; DIARRHEA; FISSURE IN ANO; HUMANS; ILEOSTOMY; MAGNETIC RESONANCE IMAGING; MALE; PREDNISOLONE; SEIZURES; SYNDROME; VISION DISORDERS;

EID: 63649095730     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31818aedb4     Document Type: Article

References (17)

1. Van Deventer SJ. Targeting TNF alpha as a key cytokine in the inflammatory processes of Crohn's disease - the mechanisms of action of infliximab. Aliment Pharmacol Ther 1999;13 (Suppl 4): 3-8.
2. Sandborn WJ, Loftus EV. Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease. Gut 2004;53:780-2.
3. Ljung T, Karlen P, Schmidt D, et al. Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County. Gut 2004;53:849-53.
4. Rosh JR, Oliva-Hemker M. Infliximab use and hepatosplenic T cell lymphoma: questions to be asked and lessons learned. J Pediatr Gastroenterol Nutr 2007;44:165-7.
5. Jarand J, Zochodne DW, Martin LO, et al. Neurological complications of infliximab. J Rheumatol 2006;33:1018-20.
6. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334: 494-500.
7. Bakshi R, Bates VE, Mechtler LL, et al. Occipital lobe seizures as the major clinical manifestation of reversible posterior leukoence-phalopathy syndrome: magnetic resonance imaging findings. Epilepsia 1998;39:295-9.
8. Barabino A, Castellano E, Gandullia P, et al. A girl with severe fistulizing Crohn's disease. Dig Liver Dis 2000;32:792-4.
9. Cosottini M, Lazzarotti G, Ceravolo R, et al. Cyclosporine-related posterior reversible encephalopathy syndrome (PRES) in non-transplant patient: a case report and literature review. Eur J Neurol 2003;10:461-2.
10. Wong R, Beguelin GZ, de Lima M, et al. Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation. Br J Haematol 2003; 122:128-34.
11. Ito Y, Arahata Y, Goto Y, et al. Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol 1998;19:415-7.
12. Kurahashi H, Okumura A, Koide T, et al. Posterior reversible encephalopathy syndrome in a child with bronchial asthma. Brain Dev 2006;28:544-6.
13. Allen JA, Adlakha A, Bergethon PR. Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancer. Arch Neurol 2006;63: 1475-8.
14. Glusker P, Recht L, Lane B. Reversible posterior leukoencephalo-pathy syndrome and bevacizumab. N Engl J Med 2006;354:980-2. discussion 980-982.
15. Van Assche G, Van Ranst M, Sciot R, et al. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med 2005;353:362-8.
16. Lamy C, Oppenheim C, Meder JF, et al. Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging 2004;14:89- 96.
17. Stott VL, Hurrell MA, Anderson TJ. Reversible posterior leukoen-cephalopathy syndrome: a misnomer reviewed. Intern Med J 2005;35:83-90.